Clinical Trial Update: Palliative Radiotherapy With Lurbinectedin in Patients With Extensive Stage Small Cell Lung Cancer [Phase 1]

View source ↗

Summary

A Phase 1 trial at Emory University is evaluating palliative radiotherapy in combination with lurbinectedin for extensive-stage small cell lung cancer and is cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Lurbinectedin (lurbinectedin)
• Zepzelca (lurbinectedin)

Snippet

Sponsor: Emory University | Conditions: Extensive Stage Lung Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 | Phase 1 | Status: RECRUITING